The social value of fluphenazine decanoate

Abstract

The Medical Research Council (England) conducted a double blind placebo controlled trial of fluphenazine decanoate as a form of maintenance therapy for schizophrenic out-patients. The results clearly demonstrated the clinical and social value of the drug in minimizing positive psychotic features, in preventing relapse and thereby alleviating distress amongst the parents of single patients and the wives of married patients. The drug allows the patients to fulfill normal social role expectations.